Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
6.02
-0.19 (-3.06%)
Apr 25, 2025, 3:04 PM CST
SHE:002550 Revenue
Changzhou Qianhong Biopharma CO.,LTD had revenue of 450.88M CNY in the quarter ending March 31, 2025, a decrease of -2.22%. This brings the company's revenue in the last twelve months to 1.52B, down -9.07% year-over-year. In the year 2024, Changzhou Qianhong Biopharma CO.,LTD had annual revenue of 1.53B, down -15.88%.
Revenue (ttm)
1.52B
Revenue Growth
-9.07%
P/S Ratio
4.96
Revenue / Employee
1.42M
Employees
1,067
Market Cap
7.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.53B | -288.03M | -15.88% |
Dec 31, 2023 | 1.81B | -489.28M | -21.24% |
Jan 1, 2023 | 2.30B | 428.61M | 22.86% |
Jan 1, 2022 | 1.87B | 207.33M | 12.43% |
Dec 31, 2020 | 1.67B | -7.55M | -0.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
Aier Eye Hospital Group | 20.98B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |